First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension

Lianne M Geerdink, Harald Bertram, Georg Hansmann

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension'. Together they form a unique fingerprint.

Medicine and Dentistry